Norstella

Citeline Podcasts

Business EN ↓ 651 episodes

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Be sure to visit the podcast's website and support the creator: www.citeline.com

Author

Norstella

Category

Business

Podcast website

www.citeline.com

Latest episode

Nov 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI 18.10.2024

Pink Sheet reporter and editors discuss an emerging pharma strategy to avoid Medicare price negotiations (:25), legal wrangling related to compounding GLP-1 drugs for obesity and diabetes (14:20), and the varying opinions of FDA officials on the acceptability of artificial intelligence models that are not fully explainable (29:08) #pharma #business More On These Topics From The Pink Sheet Keytruda...

빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast) 17.10.2024

빅파마들은 세포유전자 치료제를 출시하면서 이러한 치료의 비용과 복잡성이라는 현실적인 문제에 직면해 있습니다. 최근 개최된 메사 세포유전자 회의를 취재한 Scrip 기사를 요약한 내용입니다. https://scrip.citeline.com/SC151041/Big-Pharma-Faces-Cell-And-Gene-Therapy-Market-Realities Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini

China Biopharma Podcast - 16 October 2024 (Chinese language) 16.10.2024

Dexter Yan回顾了他在国庆长假前和阿斯利康全球执行副总裁-生物制药研发负责人Sharon Barr的采访。此外,本期播客迎来了Citeline Insights团队在上海的新成员、资深记者Xu Hu。她分享了先为达生物伊诺格鲁肽的最新III期临床数据,以及中国律师对美国生物安全法案影响的分析。

Scrip's Five Must-Know Things - 15 October 2024 15.10.2024

Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 October 2024. In this episode: making cell and gene therapies more accessible; Roche’s obesity plans; Biosecure and Indian firms; IPOs begin to recover; and Nxera looks to the future. https://scrip.citeline.com/SC151048/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/set...

Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway 11.10.2024

Introduction: Pink Sheet reporter and editors discuss experts’ experience helping drug sponsors negotiate prices with CMS (:33) and the FDA’s proposal for a new pathway to update vaccines before a pandemic is declared (12:02). More On These Topics From The Pink Sheet: Perspectives From The Front Lines: Navigating The First Round Of Medicare Price Negotiation: https://pink.citeline.com/PS155353/Per...

Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch 11.10.2024

Join us for a discussion on pediatric psoriasis and the importance of collaboration across specialties to improve treatment outcomes.

COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky 11.10.2024

Join us for a discussion on COPD and inhaler choice.

Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies 08.10.2024

Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by current epinephrine injectors, In Vivo questions the current and future progression of Neffy.

Alpha-Synuclein Testing Comes of Age 04.10.2024

In the latest episode of the In Vivo podcast, Russ Lebovitz, the co-founder and scientist behind Amprion, a diagnostics company, discusses the role of alpha-synuclein misfolding in neurodegenerative diseases and how early alpha-synuclein detection has the potential to mitigate the impacts of diseases ranging from Parkinson's disease to Lewy body dementia.

Q&A Session: PIK3CA Mutations and Breast Cancer 03.10.2024

Join us for an informative discussion about PIK3CA testing and treatment with Dr. Neil Iyengar

Conference Catch-Up: LSX World Congress USA 2024 02.10.2024

Discover the game-changing insights from the LSX World Congress USA! Join Janelle Hart, Managing Editor at Citeline, a Norstella Company, as she explores the key takeaways from the LSX World Congress USA meeting. In this episode, Janelle sits down with Tony Shi, Principal and Head of Digital Health and Access Innovation Strategy, and Eric Boyda, Consultant at The Dedham Group, to unpack the insigh...

The Future Of Drug R&D Is Self-Driving 30.09.2024

In the latest episode of the In Vivo podcast, Alan Aspuru-Guzik, a pioneer in chemical engineering who holds many positions, talks about how he is folding in robotic automation, generative AI and quantum computing in his self-driving lab.

Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO 27.09.2024

Pink Sheet reporters and editors discuss Pfizer’s abrupt decision to withdraw Oxbryta (:32), the US FDA’s Oncologic Drugs Advisory Committee bringing sponsors of approved products back to discuss labeling changes while competitors are pending (10:46), and the new CEO of a generic industry trade association (27:34). More On These Topics From The Pink Sheet Pfizer Withdraws Oxbryta, But Overall Mark...

Challenges in the Development and Manufacturing of ADCs 24.09.2024

In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu Culie, Head of Development and GMP Manufacturing, GTP Bioways, Olon Group, to discuss the challenges in the development and manufacturing of ADCs.

September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up 19.09.2024

Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology. Other platforms (in addition to SoundCloud):​ Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​ Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEw...

Health-Related Quality of Life Considerations In Clinical Trials 16.09.2024

In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials. Listen now.

Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care 13.09.2024

In this episode, HBW chats with Neil D’Souza, CEO of Makersite GmbH, a Stuttgart, Germany-based data software company that offers product data management tools that enable personal care firms to manage product sustainability, cost and compliance. D’Souza provides his take on what defines sustainable product development and how companies can use technologies such as “digital twin” product models to...

Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging 13.09.2024

Introduction: Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commercial featuring Serena Williams, and its impact on drug promotion (:36), as well as the now growing list of legal cases targeting agency decisions with Chevron deference overturned (13:32). More On These Topics From The Pink Sheet Celebs Bring Extra Scru...

September 2024 Datamonitor Healthcare Podcast: Diving into the TME 13.09.2024

Emma and Summer meet with oncology analyst Flora to discuss the therapeutic potential of exploring the tumor microenvironment. Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​ Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz​ TuneIn - https://tunein.c...

The Generics Bulletin Podcast: Recent And Upcoming Industry Events 12.09.2024

Generics Bulletin's editorial team discusses recent conferences held by Medicines for Europe and the AAM, while looking ahead to the key off-patent industry events on the calendar over the next few months and beyond.

【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast) 10.09.2024

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら 「Multiple Chinese Firms Expand Global Phase III Trials To Japan(邦訳:中国企業、第三相グローバル治験の地域を続々と日本に拡大)」  https://scrip.citeline.com/SC150842/Multiple-Chine...

J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast) 09.09.2024

호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다. https://scrip.citeline.com/SC150846/JJ-Interested-In-Differentiated-Obesity-Assets Playlist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini

Scrip's Five Must-Know Things - 9 September 2024 09.09.2024

Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in differentiated obesity assets; Kerendia hits in heart failure; strong HERCULES data keep Sanofi’s MS plans alive; WCLC preview; and Mankind sets eyes on 5x growth. https://scrip.citeline.com/SC150865/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: sou...

Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban 06.09.2024

Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to sunset on 1 October (:30), as well as an upcoming agency advisory committee meeting on potentially banning compounding of the now withdrawn pre-term birth prevention drug Makena (18:39). More On These Topics From The Pink Sheet US FDA’s Rare Pediatric V...

Scrip's Five Must-Know Things - 2 September 2024 02.09.2024

Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking continues apace; a look at cell therapies in Japan; Pfizer’s new US digital consumer platform; Galapagos’s US point of care CAR-T study; and Novartis partners with Lindy on biologics delivery. https://scrip.citeline.com/SC150827/Quick-Listen-Scrips-Fiv...

Listen to the Citeline Podcasts podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.